8-K: TriplePoint Venture Growth BDC Corp. Enters $75 Million At-the-Market Sales Agreement

Sentiment:

Sales Agreement


TriplePoint Venture Growth BDC Corp. has entered into a sales agreement to offer up to $75 million of its common stock through an at-the-market program.

Capital raiseThe company has entered into a sales agreement to offer up to $75 million of its common stock.The offering will be conducted through an at-the-market program.The company may also enter into a separate sales agreement with another party as an alternative sales agent.

Summary

  • TriplePoint Venture Growth BDC Corp. has established an at-the-market (ATM) offering program to sell up to $75 million of its common stock.
  • The sales agreement is with UBS Securities LLC, who will act as the sales agent.
  • The company may also enter into a separate sales agreement with another party as an alternative sales agent.
  • The aggregate offering price of shares sold under both agreements will not exceed $75 million.
  • The sales agent will use commercially reasonable efforts to sell shares at prevailing market prices or negotiated prices.
  • The sales agent's commission will be a maximum of 2.00% of the gross sales price of the shares.
  • The company will receive net proceeds after deducting the sales agent's commission and any transaction fees.
  • The company has terminated a previous sales agreement dated September 30, 2022, concurrently with the effectiveness of this new agreement.

Sentiment

Score: 7

Explanation: The document is a standard agreement for an at-the-market offering, which is a common practice for BDCs. The terms are reasonable and the offering provides flexibility for the company to raise capital. There are no significant red flags, but the success of the offering depends on market conditions.

Positives

  • The at-the-market offering provides a flexible way for the company to raise capital.
  • The agreement allows for sales at prevailing market prices, potentially maximizing proceeds.
  • The company has the option to use an alternative sales agent in the future.
  • The termination of the prior sales agreement simplifies the company's capital raising strategy.

Negatives

  • The sales agent is not obligated to sell any specific amount of shares.
  • The company will incur expenses related to the offering, including legal and filing fees.
  • The company may be subject to market fluctuations and may not be able to sell all shares at desired prices.
  • The sales agent may be deemed an underwriter, which could lead to additional scrutiny.

Risks

  • The company may not be able to sell all $75 million of shares.
  • Market conditions could impact the price at which shares are sold.
  • The sales agent's efforts are subject to its normal trading practices and may not always result in sales.
  • The company is exposed to potential liabilities related to the offering, including those under the Securities Act.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes, as described in the prospectus.

Industry Context

At-the-market offerings are a common method for BDCs to raise capital, providing flexibility and potentially reducing dilution compared to traditional underwritten offerings. This allows the company to take advantage of market conditions and raise capital as needed.

Comparison to Industry Standards

  • The 2.00% commission is within the typical range for at-the-market offerings by BDCs.
  • Many BDCs use ATM programs to raise capital, making this a standard practice in the industry.
  • The $75 million offering size is consistent with the capital needs of similar-sized BDCs.
  • Comparable BDCs such as Ares Capital Corporation (ARCC) and Main Street Capital Corporation (MAIN) also utilize ATM programs as part of their capital management strategies.

Stakeholder Impact

  • Shareholders may experience dilution if the full $75 million is raised.
  • The company will have additional capital to invest, potentially leading to increased earnings.
  • The offering may impact the company's stock price, depending on market conditions.
  • The company's financial position will be strengthened by the capital raise.

Next Steps

  • The company will begin selling shares through the sales agent as per the terms of the agreement.
  • The company may enter into an alternative sales agreement with another party.
  • The company will file required reports with the SEC regarding the sales of shares.

Key Dates

DateDescription
February 18, 2014The Company entered into an Investment Advisory Agreement, an Administration Agreement, a License Agreement, and the Adviser entered into a Staffing Agreement.
March 5, 2014The Company filed the 1940 Act Notification with the Commission.
September 30, 2022Date of the prior sales agreement that was terminated.
March 5, 2024The Company initially filed the Registration Statement on Form N-2 with the SEC.
March 6, 2024The Company filed its annual report on Form 10-K with the Commission.
March 8, 2024The Company filed its definitive proxy statement on Schedule 14A with the Commission.
April 18, 2024The SEC declared the Company's registration statement effective and the date of the base prospectus.
May 2, 2024The Company entered into the new sales agreement and the date of the prospectus supplement.
May 28, 2024Settlement for sales of Shares will occur on the first business day that is also a trading day for NYSE.

Keywords

at-the-market offering, common stock, sales agreement, UBS Securities LLC, capital raise, business development company, BDC, securities offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.